About: Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article by Josep M. Llovet et al published January 2000 in Hepatology

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) wüsseschaftlicher Artikel, wo im Johr 2000 veröffentlicht worden isch (gsw) наукова стаття, опублікована в січні 2000 (uk) article scientifique publié en 2000 (fr) im Jahr 2000 veröffentlichter wissenschaftlicher Artikel (de) article by Josep M. Llovet et al published January 2000 in Hepatology (en)
publication date	wds:Q58022064-034B9AB0-55A8-43BB-A11D-530457B7FD4A
publication date	2000-01-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q58022064-EE1A2251-2D30-43F8-A2EF-92004F082E33
language of work or name	English
cites work	wds:Q58022064-098FDDA2-95EB-417F-87CA-D1E53B4509F3 wds:Q58022064-0B33B6B4-3EBE-43E3-99F7-BA6C5F952EC1 wds:Q58022064-0ECA5FFB-6CCC-4E26-9C3F-152E1BE31BAD wds:Q58022064-112542A2-12D4-424F-94F0-8C0F82F35658 wds:Q58022064-118707AB-21CF-4C61-A61D-A77AA80DB327 wds:Q58022064-23A7296A-3EA0-4D36-8772-4E2C83DBDE1E wds:Q58022064-281DDA67-F97B-4159-BF6D-8DFA63145E48 wds:Q58022064-289C1EFF-0175-429C-B19E-306606A5EE42 wds:Q58022064-3BA5892D-530D-4219-907D-2964A9ABBDBC wds:Q58022064-4A94FDB9-1D55-401D-8F06-C0126471D61E wds:Q58022064-4C06B22E-654D-4234-956C-4421CA55CB4D wds:Q58022064-5B989251-8122-43FD-9D15-D13721D2D8DB wds:Q58022064-5D3B81F2-7CAC-402C-842D-C071B1B0F200 wds:Q58022064-6A2F11F2-AF3F-4EF4-A29C-33B4B5777F55 wds:Q58022064-6B7F66F1-E8DB-4C5B-B58D-DF7D145AA56F wds:Q58022064-7F4D9FEE-7EE4-424B-9E1A-D4132A6177B9 wds:Q58022064-8366D710-C106-47F9-854B-137E958FBE1E wds:Q58022064-AD6E6944-025C-4772-85EC-9ACF645AE9B2 wds:Q58022064-B3C95CE1-EAFE-4DAB-884F-A7829F314191 wds:Q58022064-B69CEF4A-72CA-427A-96ED-ED09DE918AD8 wds:Q58022064-B757744E-8F50-4632-8E49-B09E65C9B0D9 wds:Q58022064-B8DA1C2A-3074-49A8-8968-0872E2ADD052 wds:Q58022064-B929A86C-808B-4055-AF60-42843817BF26 wds:Q58022064-BFF64164-3A8C-493A-8C08-029C527CA7E7 wds:Q58022064-C88C5CC2-7F04-4961-A11B-F496C6DE60BB wds:Q58022064-CBF2AECD-D401-4736-94DF-666C887D24F8 wds:Q58022064-D0F7075B-5314-417B-9CA4-A418B0CB600B wds:Q58022064-DC09ACFB-15F3-49AA-ADEE-E81E2A4F9CBB wds:Q58022064-E582E800-A055-41FA-8DBE-07079DFC9FE5 wds:Q58022064-F1172ACF-5CB7-4A4C-87FD-6D41C6887F24
cites work	Side effects of alpha interferon in chronic hepatitis C. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Treatment of hepatocellular carcinoma Reporting results of cancer treatment Transection of the oesophagus for bleeding oesophageal varices Renal function abnormalities, prostaglandins, and effects of nonsteroidal anti-inflammatory drugs in cirrhosis with ascites. An overview with emphasis on pathogenesis Performance status assessment in cancer patients. An inter-observer variability study Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials Review article: Overview of medical treatments in unresectable hepatocellular carcinoma--an impossible meta-analysis? Recombinant interferon-α in inoperable hepatocellular carcinoma: A randomized controlled trial Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Prognosis of hepatocellular carcinoma: the BCLC staging classification Durable clinical and pathologic response of hepatocellular carcinoma to systemic and hepatic arterial administration of platinol, recombinant interferon alpha 2B, doxorubicin, and 5-fluorouracil: a communication Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials Treatment of hepatocellular carcinoma with tamoxifen: A double-blind placebo-controlled trial in 120 patients Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients Rising incidence of hepatocellular carcinoma in the United States Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis Liver transplantation for small hepatocellular carcinoma: The tumor-node-metastasis classification does not have prognostic power Hepatic arterial infusion of floxuridine, leucovorin, doxorubicin, and cisplatin for hepatocellular carcinoma: effects of hepatitis B and C viral infection on drug toxicity and patient survival Interferons in the treatment of human cancer Recombinant alpha 2 interferon is superior to doxorubicin for inoperable hepatocellular carcinoma: a prospective randomised trial Low serum alpha-fetoprotein level in patients with hepatocellular carcinoma as a predictor of response to 5-FU and interferon-alpha-2b 5-Fluorouracil and alpha-interferon in hepatocellular carcinoma Combined doxorubicin and alpha-interferon therapy of advanced hepatocellular carcinoma Clinical pilot study of intrahepatic arterial chemotherapy with methotrexate, 5-fluorouracil, cisplatin and subcutaneous interferon-alpha-2b for patients with locally advanced hepatocellular carcinoma Treatment of hepatocellular carcinoma with recombinant leucocyte interferon: a pilot study A prospective trial of recombinant human interferon alpha 2B in previously untreated patients with hepatocellular carcinoma. The Gastrointestinal Tumor Study Group
author name string	wds:Q58022064-05979F50-628B-49B0-81D9-F96C3363DA7F wds:Q58022064-2AAF7790-5F49-4EF8-B185-6067F18A8AAC wds:Q58022064-5FA1002B-5EBF-4A72-92DB-81152E8BDA5D wds:Q58022064-635AFBC8-A78C-40DA-BBCA-A585FDF7504E wds:Q58022064-9AD4F1E3-C9FB-4E73-B98E-5AB0D4CBC3DE wds:Q58022064-A8ACC07B-724F-425C-9B19-86237777D076 wds:Q58022064-BBDDEE74-852F-4413-A2A1-5C815E195C47 wds:Q58022064-C6E5DF67-913D-4229-88AD-E3AF1C09F062 wds:Q58022064-F02D1C13-CA30-4184-8FF1-F3B01629AA1A
author name string	Carmen Ayuso Jordi Bruix Margarita Sala Ramon Vilana Lluís Castells Víctor Vargas Joan Rodés Lluís Bianchi Yanette Suarez
rdfs:label	Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma (en) Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma (nl)
skos:prefLabel	Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma (en) Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma (nl)
name	Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma (en) Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma (nl)
author	wds:Q58022064-DCD2491C-F633-44B4-B02D-198F8F054811
author	Josep M. Llovet
title	wds:Q58022064-9C4279B5-D9CC-4ADB-B502-EB03BB5C7291
title	Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma (en)
page(s)	wds:Q58022064-039BD752-51A9-42C9-8537-DA9C810830D6

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software